Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Motivational interviewing to improve client engagement in addiction treatment

Official title: Adapting Intake Procedures to Improve Treatment Delivery in Addiction Treatment

Run by University of New Mexico · NCT05489068 · Data updated 2026-11-12

This study is testing if using Motivational Interviewing during the first meeting can help adults starting addiction treatment feel more engaged compared to regular intake methods.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity of New Mexico
Academic / other
Locations1 site (Albuquerque, New Mexico)
StatusRecruiting
StartedMarch 16, 2022
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedNovember 2, 2026
Trial IDNCT05489068 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adults seeking treatment for alcohol or other drug use who are physically withdrawn from substances.

Probably not a fit

Patients experiencing severe withdrawal symptoms or those who are actively psychotic, manic, or suicidal may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Motivational Interviewing at Intake (MII) compared to standard intake procedures in enhancing client engagement among adults seeking outpatient addiction treatment. It employs a hybrid effectiveness-implementation design to assess both the impact on client engagement and the feasibility of integrating MII into standard practice. Personnel feedback will also be collected to understand the implementation climate before and after the training in Motivational Interviewing. The study aims to provide insights into improving treatment adherence for substance-related disorders.

Why it matters

Potential benefit: If successful, this approach could significantly enhance client engagement in addiction treatment, leading to better treatment outcomes.

How similar studies have gone: Previous studies have shown that motivational interviewing can improve engagement in various treatment settings, suggesting a promising approach in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (client participants):

* English-speaking adults seeking treatment for alcohol or other drug use at one of two outpatient addiction treatment programs
* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures
* Physically withdrawn from alcohol or other drugs

Inclusion Criteria (personnel participants):

* English-speaking adults currently employed at one of the two outpatient addiction treatment programs
* Provision of electronic informed consent

Exclusion Criteria (client participants):

* Experiencing severe withdrawal symptoms
* Actively psychotic, manic, and/or suicidal

Exclusion Criteria (personnel participants):

* current position: facility owner or clinical director

Where it's running

  • UNM Psychology Clinic
    Albuquerque, New Mexico, United States
    Recruiting

Study contacts

  • Principal investigator: Margo Hurlocker, PhD — University of New Mexico
  • Study coordinator: Margo Hurlocker, PhD
  • Email: mhurlocker@unm.edu
  • Phone: (505) 596-0578

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.